Pharmaceutical intermediates for Anti-hepatitis C

Pharmaceutical intermediates

Intermediates for anti-hepatitis C

OSAT Group is a comprehensive pharmaceutical intermediates solution and manufacturer, we have a systematic series of intermediates for different applications, supporting customized R&D and production with high-quality products, competitive prices, and excellent full-process services as the core competitiveness.

CAS 1173807-85-6

(1R,2S)-1-Amino-2-vinyl cyclopropane carboxylic acid ethyl ester hemisulfate

Main Use: Precursor for Simeprevir, used for the treatment of hepatitis C.

CAS1042695-87-3

(1R,2R,4S)-2-[(5-Hexen-1-ylmethylamino)carbonyl]-4-[[7-methoxy-8-methyl-2-[4-isopropyl-2-thiazolyl]-4-quinolinyl]oxy]cyclopentanecarboxylic acid methyl ester

Main Use: Pharmaceutical Intermediates for Simeprevir, with antiviral activity against hepatitis C.

CAS 1334513-02-8

N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphoryl]-L-alanine isopropyl ester

Main Use: Pharma Intermediates for Sofosbuvir are used in the synthesis of antiviral drugs against hepatitis C.

CAS 874638-80-9

(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentofuranosonic acid gamma-lactone 3,5-dibenzoate

Main Use: Precursor for Sofosbuvir, with antiviral activity against hepatitis C.

CAS 817204-32-3

(2’R)-N-Benzoyl-2′-deoxy-2′-fluoro-2′-methylcytidine 3′,5′-dibenzoate

Main Use: Pharmaceutical Intermediates for Sofosbuvir, enhancing the antiviral efficacy of the drug.

CAS 863329-66-2

2’R)-2′-Deoxy-2′-fluoro-2′-methyluridine

Main Use: Pharma Intermediates for Sofosbuvir are used in the production of antiviral drugs against hepatitis C.